Aneurysm: Epidemiology Aetiology and Pathophysiology

Studies in Mechanobiology, Tissue Engineering and Biomaterials

Volumn 7, Issue , 2011, Pages 1-33

  Sakalihasan, Natzi ^a   Kuivaniemi, Helena ^b   Nusgens, Betty ^c   Durieux, Rodolphe ^a   Defraigne, Jean Olivier ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b WEIS CENTER FOR RESEARCH   (United States)

^c UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Abdominal Aortic Aneurysm; Aortic Aneurysm; Aortic Wall; Intracranial Aneurysm

Indexed keywords

EID: 84866904028     PISSN: 18682006     EISSN: 18682014     Source Type: Book Series    
DOI: 10.1007/8415_2010_47     Document Type: Chapter

References (189)

1. Acosta, S., Ogren, M., Bengtsson, H., et al.: Increasing incidence of ruptured abdominal aortic aneurysm: a population-based study. J. Vasc. Surg. 44(2), 237–243 (2006)
2. Achneck, H., Modi, B., Shaw, C., et al.: Ascending thoracic aneurysms are associated with decreased systemic atherosclerosis. Chest 128(3), 1580–1586 (2005)
3. Ailawadi, G., Eliason, J.L., Roelofs, K.J., et al.: Gender differences in experimental aortic aneurysm formation. Arterioscler. Thromb. Vasc. Biol. 24(11), 2116–2122 (2004)
4. Alexander, J.J.: The pathobiology of aortic aneurysms. J. Surg. Res. 117(1), 163–175 (2004)
5. Allaire, E., Forough, R., Clows, M., et al.: Local overexpression of TIMP-1 prevent aortic aneurysm degeneration and rupture in a rat model. J. Clin. Invest. 102, 1413–1420 (1998)
6. Allaire, E., Hasenstab, D., Kenagy, R.D., et al.: Prevention of aneurysm development and rupture by local overexpression of plasminogen activator inhibitor-1. Circulation 98(3), 249–255 (1998)
7. Aneurysm Detection and Management Veterans Affairs Cooperative Study Group: Immediate repair compared with surveillance of small abdominal aortic aneurysms. N. Engl. J. Med. 346, 1437–1444 (2002)
8. Anidjar, S., Salzman, L., Gentric, D., et al.: Elastase-induced experimental aneurysms in rats. Circulation 82, 973–981 (1990)
9. Ashton, H.A., Buxton, M.J., Day, N.E., et al.: The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet 360(9345), 1531–1539 (2002)
10. Barker, D.J.: Fetal origins of coronary heart disease. BMJ 311(6998), 171–174 (1995)
11. Bengtsson, H., Sonesson, B., Bergqvist, D.: Incidence and prevalence of abdominal aortic aneurysms, estimated by necropsy studies and population screening by ultrasound. Ann. NY Acad. Sci. 18, 1–24 (1996)
12. Bickerstaff, L.K., Pairolero, P.C., Hollier, L.H., et al.: Thoracic aortic aneurysms: a population-based study. Surgery 92, 1103–1108 (1982)
13. Bilguvar, K., Yasuno, K., Niemela, M., et al.: Susceptibility loci for intracranial aneurysm in European and Japanese populations. Nat. Genet. 40, 1472–1477 (2008)
14. Blanchard, J.F., Armenian, H.K., Friesen, P.P.: Risk factors for abdominal aortic aneurysm: results of a case-control study. Am. J. Epidemiol. 151(6), 575–583 (2000)
15. Boddy, A.M., Lenk, G.M., Lillvis, J.H., et al.: Basic research studies to understand aneurysm disease. Drug News Perspect. 21, 142–148 (2008)
16. Borkett-Jones, H.J., Stewart, G., Chilvers, A.S.: Abdominal aortic aneurysms in identical twins. J. Royal Soc. Med. 81, 471–473 (1988)
17. Brown, L.C., Powell, J.T.: Risk factors for aneurysm rupture in patients kept under ultrasound surveillance. UK small aneurysm trial participants. Ann. Surg. 230(3), 289–296 (1999). discussion 296–7
18. Brady, A.R., Thompson, S.G., Fowkes, F.G., et al.: Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance. Circulation 110(1), 16–21 (2004)
19. Buckley, C., Wyble, C.W., Borhani, M., et al.: Accelerated enlargement of experimental abdominal aortic aneurysms in a mouse model of chronic cigarette smoke exposure. J. Am. Coll. Surg. 199(6), 896–903 (2004)
20. Cambria, R.A., Glovicki, P., Stanson, A.W., et al.: Outcome and expansion rate of 57 thoraco-abdominal aortic aneurysms managed nonoperatively. Am. J. Surg. 170(2), 213–217 (1995)
21. Campa, J.S., Greenhalgh, R.M., Powel, J.T.: Elastin degradation in abdominal aortic aneurysms. Atherosclerosis 65, 13–21 (1987)
22. Carmeliet, P., Moons, L., Lijnen, R., et al.: Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat. Genet. 17(4), 439–444 (1997)
23. Carrell, T.W., Burnand, K.G., Wells, G.M., et al.: Stromelysin-1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase-3 are overexpressed in the wall of abdominal aortic aneurysms. Circulation 105(4), 477–482 (2002)
24. Choke, E., Cockerill, G.W., Laing, K., et al.: Whole genome-expression profiling reveals a role for immune and inflammatory response in abdominal aortic aneurysm rupture. Eur. J. Vasc. Endovasc. Surg. 37, 305–310 (2009)
25. Clifton, M.A.: Familial abdominal aortic aneurysms. Br. J. Surg. 64(11), 765–766 (1977)
26. Clouse, W.D., Hallett Jr, J.W., Schaff, H.V., et al.: Acute aortic dissection: population-based incidence compared with degenerative aortic aneurysm rupture. Mayo Clin. Proc. 79(2), 176–180 (2004)
27. Clouse, W.D., Hallett Jr, J.W., Schaff, H.V., et al.: Improved prognosis of thoracic aortic aneurysms: a population-based study. JAMA 280(22), 1926–1929 (1998)
28. Coady, M.A., Stockwell, P.H., Robich, M.P., et al.: Should aortas in patients with bicuspid aortic valve really be resected at an earlier stage than tricuspid? CON. Cardiol. Clin. 28(2), 299–314 (2010)
29. Cripe, L., Andelfinger, G., Martin, L.J., et al.: Bicuspid aortic valve is heritable. J. Am. Coll. Cardiol. 44(1), 138–143 (2004)
30. Curci, J.A., Thompson, R.W.: Adaptive cellular immunity in aortic aneurysms: cause, consequence, or context? J. Clin. Invest. 114(2), 168–171 (2004)
31. Curci, J.A., Liao, S., Huffman, M.D., et al.: Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. J. Clin. Invest. 102(11), 1900–1910 (1998)
32. Davis, V., Persidskaia, R., Baca-Regen, L., et al.: Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 18(10), 1625–1633 (1998)
33. Defawe, O.D., Colige, A., Lambert, C.A., et al.: TIMP-2 and PAI-1 mRNA levels are lower in aneurysmal as compared to athero-occlusive abdominal aortas. Cardiovasc. Res. 60(1), 205–213 (2003)
34. Defawe, O.D., Colige, A., Deroanne, C., et al.: Mechanical strain modulates monocyte chemotic protein-1 and IL-1beta mRNA expression by cultured human aortic smooth muscle cells. Presented at the XIIIth International Vascular Biology Meeting, June 1–5, Toronto (2004)
35. Defawe, O.D., Hustinx, R., Defraigne, J.O., et al.: Distribution of F-18 fluorodeoxyglucose (F-18 FDG) in abdominal aortic aneurysm: high accumulation in macrophages seen on PET imaging and immunohistology. Clin. Nucl. Med. 30(5), 340–341 (2005)
36. Deka, R., Koller, D.L., Lai, D., et al.: The relationship between smoking and replicated sequence variants on chromosome 8 and 9 with familial intracranial aneurysm. Stroke 41(6), 1132–1137 (2010)
37. Della Corte, A., Bancone, C., Quarto, C., et al.: Predictors of ascending aortic dilatation with bicuspid aortic valve: a wide spectrum of disease expression. Eur. J. Cardiothorac. Surg. 37, 397–405 (2007)
38. Deng, G.G., Martin-McNulty, B., Sukovich, D.A., et al.: Urokinase-type plasminogen activator plays a critical role in angiotensin II-induced abdominal aortic aneurysm. Circ. Res. 92(5), 510–517 (2003)
39. Diehm, N., Baumgartner, I.: Determinants of aneurysmal aortic disease. Circulation 119(16), 2134–2135 (2009)
40. Dingemans, K.P., Teeling, P., Lagendijk, J.H., Becker, A.E.: Extracellular matrix of the human aortic media: an ultrastructural, histochemical and immunohistochemical study of the adult aortic media. Anat. Rec. 258, 1–14 (2000)
41. Dobrin, P.B.: Animal models of aneurysms. Ann. Vasc. Surg. 13(6), 641–648 (1999)
42. Dubick, M.A., Keen, C.L., DiSilvestro, R.A., et al.: Antioxidant enzyme activity in human abdominal aortic aneurysmal and occlusive disease. Proc. Soc. Exp. Biol. Med. 220(1), 39–45 (1999)
43. El-Benna, J., Dang, P.M., Périanin, A.: Peptide-based inhibitors of the phagocyte NADPH oxidase. Biochem. Pharmacol. 80(6), 778–785 (2010)
44. Elefteriades, J.A., Farkas, E.A.: Thoracic aortic aneurysm clinically pertinent controversies and uncertainties. J. Am. Coll. Cardiol. 55, 841–857 (2010)
45. Elefteriades, J.A., Rizzo, J.A.: Epidemiology, prevalence, incidence, trends. In: Elefteriades, J.A. (ed.) Acute Aortic Disease, pp. 89–98. Informa Healthcare, New York, NY (2008)
46. Elmore, J.R., Obmann, M.A., Kuivaniemi, H., et al.: Identification of a genetic variant associated with abdominal aortic aneurysms on chromosome 3p12.3 by genome wide association. J. Vasc. Surg. 49, 1525–1531 (2009)
47. Elzouki, A.N., Ryden Ahlgren, A., Lanne, T., et al.: Is there a relationship between abdominal aortic aneurysms and alpha1-antitrypsin deficiency (PiZ)? Eur. J. Vasc. Endovasc. Surg. 17(2), 149–154 (1999)
48. Erentug, V., Bozbuga, N., Omeroglu, S.N., et al.: Rupture of abdominal aortic aneurysms in Behcet’s disease. Ann. Vasc. Surg. 17(6), 682–685 (2003)
49. Eriksson, P., Jones, K.G., Brown, L.C., et al.: Genetic approach to the role of cysteine proteases in the expansion of abdominal aortic aneurysms. Br. J. Surg. 91(1), 86–89 (2004)
50. Fedak, P.W., de Sa, M.P., Verma, S., et al.: Vascular matrix remodeling in patients with bicuspid aortic valve malformations: implications for aortic dilatation. J. Thorac. Cardiovasc. Surg. 126(3), 797–806 (2003)
51. Fontaine, V., Jacob, M.P., Houard, X., et al.: Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms. Am. J. Pathol. 161(5), 1701–1710 (2002)
52. Fontaine, V., Touat, Z., Mtairag el, M., et al.: Role of leukocyte elastase in preventing cellular re-colonization of the mural thrombus. Am. J. Pathol. 164(6), 2077–2087 (2004)
53. Forsdahl, S.H., Singh, K., Solberg, S., Jacobsen, B.K.: Risk factors for abdominal aortic aneurysms: a 7-year prospective study: the Tromsø study, 1994–2001. Circulation 119(16), 2202–2208 (2009)
54. Foroud, T., Sauerbeck, L., Brown, R., et al.: FIA Study Investigators. Genome screen to detect linkage to intracranial aneurysm susceptibility genes: the Familial Intracranial Aneurysm (FIA) study. Stroke 39, 1434–1440 (2008)
55. Ghorpade, A., Baxter, B.T.: Biochemistry and molecular regulation of matrix macromolecules in abdominal aortic aneurysms. Ann. N. Y. Acad. Sci. 800, 138–150 (1996)
56. Gillum, R.F.: Epidemiology of aortic aneurysm in the United States. J. Clin. Epidemiol. 48(11), 1289–1298 (1995)
57. Giusti, B., Rossi, L., Lapini, I., et al.: Gene expression profiling of peripheral blood in patients with abdominal aortic aneurysm. Eur. J. Vasc. Endovasc. Surg. 38, 104–112 (2009)
58. Glimaker, H., Holmberg, L., Elvin, A., et al.: Natural history of patients with abdominal aortic aneurysm. Eur. J. Vasc. Surg. 5(2), 125–130 (1991)
59. Griepp, R.B., Ergin, M.A., Galla, J.D., et al.: Natural history of descending thoracic and thoracoabdominal aneurysms. Ann. Thorac. Surg. 67(6), 1927–1930 (1999)
60. Guo, D.C., Pannu, H., Tran-Fadulu, V., et al.: Mutations in smooth muscle a-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat. Genet. 39, 1488–1493 (2007)
61. Hance, K.A., Tataria, M., Ziporin, S.J., et al.: Monocyte chemotactic activity in human abdominal aortic aneurysms: role of elastin degradation peptides and 67-kD cell surface elastin receptor. J. Vasc. Surg. 35(2), 254–261 (2002)
62. Hashikata, H., Liu, W., Inoue, K., et al.: Confirmation of an association of single-nucleotide polymorphism rs1333040 on 9p21 with familial and sporadic intracranial aneurysms in Japanese patients. Stroke 41(6), 1138–1144 (2010)
63. Helgadottir, A., Thorleifsson, G., Magnusson, K.P., et al.: The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat. Genet. 40, 217–224 (2008)
64. Henderson, E.L., Geng, Y.J., Sukhova, G.K., et al.: Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. Circulation 99(1), 96–104 (1999)
65. Herron, G.S., Unemori, E., Wong, M., et al.: Connective tissue proteinases and inhibitors in abdominal aortic aneurysms. Atheroscl. Thromb. 11, 1667–1677 (1991)
66. Holdt, L.M., Beutner, F., Scholz, M., et al.: ANRIL expression is associated with atherosclerosis risk at chromosome 9p21. Arterioscler. Thromb. Vasc. Biol. 30, 620–627 (2010)
67. Holmes, D.R., Liao, S., Parks, W.C., Thompson, R.W.: Medial neovascularization in abdominal aortic aneurysms: a histopathologic marker of aneurysmal degeneration with pathophysiologic implications. J. Vasc. Surg. 21(5), 761–771 (1995). discussion 771-772
68. Huntington, K., Hunter, A.G., Chan, K.L.: A prospective study to assess the frequency of familial clustering of congenital bicuspid aortic valve. J. Am. Coll. Cardiol. 30(7), 1809–1812 (1997)
69. Isselbacher, E.M.: Thoracic and abdominal aortic aneurysms. Circulation 111(6), 816–828 (2005)
70. Ito, S., Akutsu, K., Tamori, Y., et al.: Differences in atherosclerotic profiles between patients with thoracic and abdominal aortic aneurysms. Am. J. Cardiol. 101(5), 696–699 (2008)
71. Johansson, G., Markström, U., Swedenborg, J.: Ruptured thoracic aortic aneurysms: a study of incidence and mortality rates. J. Vasc. Surg. 21, 985–988 (1995)
72. Jones, K., Powell, J., Brown, L., et al.: The influence of 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene promoter on the incidence, growth and operative risk of abdominal aortic aneurysm. Eur. J. Vasc. Endovasc. Surg. 23(5), 421–425 (2002)
73. Kazi, M., Thyberg, J., Religa, P.: Influence of intraluminal thrombus on structural and cellular composition of abdominal aortic aneurysm wall. J. Vasc. Surg. 38(6), 1283–1292 (2003)
74. Kazi, M., Zhu, C., Roy, J., et al.: Difference in matrix-degrading protease expression and activity between thrombus-free and thrombus-covered wall of abdominal aortic aneurysm. Arterioscler. Thromb. Vasc. Biol. 25(7), 1341–1346 (2005)
75. Khau Van Kien, P., Mathieu, F., Zhu, L., et al.: Mapping of familial thoracic aortic aneurysm/dissection with patent ductus arteriosus to 16p12.2–p13.13. Circulation 112, 200–206 (2005)
76. Kniemeyer, H.W., Kessler, T., Reber, P.U., et al.: Treatment of ruptured abdominal aortic aneurysm, a permanent challenge or a waste of resources? Prediction of outcome using a multi-organ-dysfunction score. Eur. J. Vasc. Endovasc. Surg. 19(2), 190–196 (2000)
77. Knox, J.B., Sukhova, G.K., Whittemore, A.D., Libby, P.: Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases. Circulation 95, 205–212 (1997)
78. Koch, A.E., Kunkel, S.L., Pearce, W.H., et al.: Enhanced production of the chemotactic cytokines interleukin-8 and monocyte chemoattractant protein-1 in human abdominal aortic aneurysms. Am. J. Pathol. 142(5), 1423–1431 (1993)
79. Koksal, C., Ercan, M., Boskurt, A.K., et al.: Abdominal aortic aneurysm or aortic occlusive disease: role of trace element imbalance. Angiology 58, 191–195 (2007)
80. Kuivaniemi, H., Tromp, G.: Search for the aneurysm susceptibility gene(s). In: Keen, R.R., Dobrin, P.B. (eds.) Development of Aneurysms, pp. 219–233. Landes Bioscience, Georgetown (2000)
81. Kuivaniemi, H., Shibamura, H., Arthur, C., et al.: Familial abdominal aortic aneurysms: collection of 233 multiplex families. J. Vasc. Surg. 37, 340–345 (2003)
82. Kuivaniemi, H., Kyo, Y., Lenk, G., Tromp, G.: Genome-wide approach to finding abdominal aortic aneurysm susceptibility genes in humans. Ann. N. Y. Acad. Sci. 1085, 270–281 (2006)
83. Kuivaniemi, H., Platsoucas, C.D., Tilson, M.D., 3rd: Aortic aneurysms: an immune disease with a strong genetic component. Circulation 117, 242–252 (2008)
84. Kuivaniemi, H., Boddy, A.M., Lillvis, J.H., et al.: Abdominal aortic aneurysms are deep, deadly and genetic. In: Sakalihasan, N., Kuivaniemi, H., Michel Liège, J.B. (eds.) Aortic aneurysms, new insights into an old problem, pp. 299–323. Liège University Press, Belgium (2008)
85. Lapière, Ch.M., Courtois, A., Nusgens, B.: Extracellular matrix proteins in normal and aneurysmal aorta. In: Sakalihasan, N., Kuivaniemi, H., Michel, J.B. (eds.) Aortic Aneurysms, New Insights into an Old Problem, pp. 67–83. Les Editions de l’Université de Liège, Liège (2008)
86. Lederle, F.A.: In the clinic. Abdominal aortic aneurysm. Ann Intern Med 150:ITC5-1-15 (2009)
87. Lederle, F.A., Johnson, G.R., Wilson, S.E., et al.: The aneurysm detection and management study screening program: validation cohort and final results. Aneurysm detection and management veterans affairs cooperative study investigators. Arch. Intern. Med. 160(10), 1425–1430 (2000)
88. Lederle, F.A., Johnson, G.R., Wilson, S.E.: Abdominal aortic aneurysm in women. J. Vasc. Surg. 34(1), 122–126 (2001)
89. Lederle, F.A., Gary, R.J., Samuel, E.W., et al.: Rupture rate of large abdominal aortic aneurysms in patients refusing or unfit for elective repair. JAMA 287(22), 2968–2972 (2002)
90. Lenk, G.M., Tromp, G., Weinsheimer, S., et al.: Whole genome expression profiling reveals a significant role for immune function in human abdominal aortic aneurysms. BMC Genomics 8, 237 (2007)
91. Liddington, M.I., Heather, B.P.: The relationship between aortic diameter and body habitus. Eur. J. Vasc. Surg. 6(1), 89–92 (1992)
92. Lillvis, J.H., Lenk, G.M., Kuivaniemi, H.: Genetics of Abdominal Aortic Aneurysms. In: Upchurch, G., Criado, E. (eds.) Aortic Aneurysms: pathogenesis and treatment, pp. 1–26. Humana Press Inc., Totowa, NJ (2009)
93. Limet, R., Sakalihassan, N., Albert, A.: Determination of the expansion rate and incidence of rupture of abdominal aortic aneurysms. J. Vasc. Surg. 14(4), 540–548 (1991)
94. Lindholt, J.S., Vammen, S., Fasting, H., Henneberg, E.W., Heickendorff, L.: The plasma level of matrix metalloproteinase 9 may predict the natural history of small abdominal aortic aneurysms. A preliminary study. Eur. J. Vasc. Endovasc. Surg. 20(3), 281–285 (2000)
95. Lindholt, J.S., Vammen, S., Juul, S., et al.: Optimal interval screening and surveillance of abdominal aortic aneurysms. Eur. J. Vasc. Endovasc. Surg. 20(4), 369–373 (2000)
96. Lindholt, J.S., Heegaard, N.H., Vammen, S., et al.: Smoking, but not lipids, lipoprotein(a) and antibodies against oxidised LDL, is correlated to the expansion of abdominal aortic aneurysms. Eur. J. Vasc. Endovasc. Surg. 21(1), 51–56 (2001)
97. Lobato, A.C., Puech-LeLeão, P.: Predictive factors for rupture of thoraco-abdominal aortic aneurysm. J. Vasc. Surg. 27(3), 446–453 (1998)
98. Longo, G.M., Xiong, W., Greiner, T.C., et al.: Matrix metalloproteinases 2 and 9 work in concert to product aortic aneurysms. J. Clin. Invest. 110(5), 625–632 (2002)
99. MacSweeney, S.T., Ellis, M., Worrell, P.C., et al.: Smoking and growth rate of small abdominal aortic aneurysms. Lancet 344(8923), 651–652 (1994)
100. Madaric, J., Vulev, I., Bartunek, J., et al.: Frequency of abdominal aortic aneurysm in patients [60 years of age with coronary artery disease. Am. J. Cardiol. 96(9), 1214–1216 (2005)
101. Majumder, P.P., St Jean, P.L., Ferrell, R.E., et al.: On the inheritance of abdominal aortic aneurysm. Am. J. Hum. Genet. 48, 164–170 (1991)
102. Mao, D., Lee, J.K., Van Vickle, S.J., Thompson, R.W.: Expression of collagenase-3 (MMP-13) in human abdominal aortic aneurysms and vascular smooth muscle cells in culture. Biochem. Biophys. Res. Commun. 261(3), 904–910 (1999)
103. Matsumura, K., Hirano, T., Takeda, K., et al.: Incidence of aneurysms in Takayasu’s arteritis. Angiology 42(4), 308–315 (1991)
104. McCormick, M.L., Gavrila, D., Weintraub, N.L.: Role of oxidative stress in the pathogenesis of abdominal aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 27(3), 461–469 (2007)
105. McGregor, J.C., Pollock, J.G., Anton, H.C.: The value of ultrasonography in the diagnosis of abdominal aortic aneurysms. Scott. Med. J. 20, 133–137 (1975)
106. McMillan, W.D., Pearce, W.H.: Increased plasma levels of metalloproteinase-9 are associated with abdominal aortic aneurysms. J. Vasc. Surg. 29(1), 122–127 (1999). discussion 127-9
107. Menashi, S., Campa, J.S., Greenhalgh, R.M., Powel, J.T.: Collagen in abdominal aortic aneurysm: typing, content and degradation. J. Vasc. Surg. 6, 578–582 (1987)
108. Michel, J.B., Thaunat, O., Houard, X., et al.: Topological determinants and consequences of adventitial responses to arterial wall injury. Arterioscler. Thromb. Vasc. Biol. 27(6), 1259–1268 (2007)
109. Milewicz, D.M., Guo, D.C., Tran-Fadulu, V., et al.: Genetic basis of thoracic aortic aneurysms and dissections: focus on smooth muscle cell contractile dysfunction. Annu. Rev. Genomics Hum. Genet. 9, 283–302 (2008)
110. Miller Jr, F.J., Sharp, W.J., Fang, X., et al.: Oxidative stress in human abdominal aortic aneurysms: a potential mediator of aneurysmal remodeling. Arterioscler. Thromb. Vasc. Biol. 22(4), 560–565 (2002)
111. Nevitt, M.P., Ballard, D.J., Hallett Jr, J.W.: Prognosis of abdominal aortic aneurysms. A population-based study. N. Engl. J. Med. 321(15), 1009–1014 (1989)
112. Newman, K.M., Jean-Claude, J., Li, H., et al.: Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall. J. Vasc. Surg. 20, 814–820 (1994)
113. Newman, M.P., Jean-Claude, J., Li, H., et al.: Cytokines that activate proteolysis are increased in abdominal aortic aneurysms. Circulation 90(5Pt 2), 1224–1227 (1994)
114. Nischan, J., Gatalica, Z., Curtis, M., et al.: Binding sites for ETS family of transcription factors dominate the promoter regions of differentially expressed genes in abdominal aortic aneurysms. Circ. Cardiovasc. Genet. 2, 565–572 (2009)
115. Nischan, J., Lenk, G.M., Boddy, A.M., et al.: Abdominal Aortic Aneurysms – a Complex Genetic Disease. In: Laurent, A., Morel, E. (eds.) Aneurysms: Types, Risks, Formation and Treatment (ISBN: 978-1-60741-557-2), pp. 35–93. Nova Science Publishers, Inc, Hauppauge, NY (2009)
116. Nistri, S., Sorbo, M.D., Marin, M., et al.: Aortic root dilatation in young men with normally functioning bicuspid aortic valves. Heart 82, 19–22 (1999)
117. Nollendorfs, A., Greiner, T.C., Nagase, H., Baxter, B.T.: The expression and localization of membrane type-1 matrix metalloproteinase in human abdominal aortic aneurysms. J. Vasc. Surg. 34(2), 316–322 (2001)
118. Nordon, I.M., Hinchliffe, R.J., Holt, P.J., et al.: Review of current theories for abdominal aortic aneurysm pathogenesis. Vascular 17(5), 253–263 (2009)
119. Norrgård, Ö., Rais, O., Ängquist, K.A.: Familial occurrence of abdominal aortic aneurysms. Surgery 95, 650–656 (1984)
120. Ogata, T., MacKean, G.L., Cole, C.W., et al.: The lifetime prevalence of abdominal aortic aneurysms among siblings of aneurysm patients is eightfold higher than among siblings of spouses: an analysis of 187 aneurysm families in Nova Scotia; Canada. J. Vasc. Surg. 42, 891–897 (2005)
121. Ogata, T., Gregoire, L., Goddard, K.A., et al.: Evidence for association between the HLA-DQA locus and abdominal aortic aneurysms in the Belgian population: a case control study. BMC Med. Genet. 7, 67 (2006)
122. Olsson, C., Thelin, S., Ståhle, E., et al.: Thoracic aortic aneurysm and dissection: increasing prevalence and improved outcomes reported in a nationwide population-based study of more than 14 000 cases from 1987 to 2002. Circulation 114, 2611–2618 (2006)
123. Pachulski, R.T., Weinberg, A.L., Chan, K.L.: Aortic aneurysm in patients with functionally normal or minimally stenotic bicuspid aortic valve. Am. J. Cardiol. 67(8), 781–782 (1991)
124. Phillippi, J.A., Klyachko, E.A., Kenny, J.P., 4th, Eskay, M.A., Gorman, R.C., Gleason, T.G.: Basal and oxidative stress–induced expression of metallothionein is decreased in ascending aortic aneurysms of bicuspid aortic valve patients circulation 119, 2498–2506 (2009)
125. Powell, J.T.: Familial clustering of abdominal aortic aneurysm–smoke signals, but no culprit genes. Br. J. Surg. 90(10), 1173–1174 (2003)
126. Powell, J.T., Brown, L.C., Greenhalgh, R.M., et al.: The rupture rate of large abdominal aortic aneurysms: is this modified by anatomical suitability for endovascular repair? Ann. Surg. 247, 173–179 (2008)
127. Pressler, V., McNamara, J.J.: Aneurysm of the thoracic aorta. Review of 260 cases. J. Thorac. Cardiovasc. Surg. 89(1), 50–54 (1985)
128. Pyo, R., Lee, J.K., Shipley JM, J., et al.: Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J. Clin. Invest. 105(11), 1641–1649 (2000)
129. Ramanath, V.S., Oh, J.K., Sundt 3rd, T.M., Eagle, K.A.: Acute aortic syndromes and thoracic aortic aneurysm. Mayo Clin. Proc. 84(5), 465–481 (2009)
130. Rao, S.K., Reddy, K.V., Cohen, J.R.: Role of serine proteases in aneurysm development. Ann. N. Y. Acad. Sci. 800, 131–137 (1996)
131. Reed, D., Reed, C., Stemmermann, G., Hayashi, T.: Are aortic aneurysms caused by atherosclerosis? Circulation 85(1), 205–211 (1992)
132. Reeps, C., Essler, M., Pelisek, J., et al.: Increased 18F-fluorodeoxyglucose uptake in abdominal aortic aneurysms in positron emission/computed tomography is associated with inflammation, aortic wall instability, and acute symptoms. J. Vasc. Surg. 48(2), 417–423 (2008)
133. Reilly, J.M.: Plasminogen activors in abdominal aortic aneurysmal disease. Ann. N. Y. Acad. Sci. 800, 151–156 (1996)
134. Rizzo, R.J., McCarthy, W.J., Dixit, S.N., et al.: Collagen types and matrix protein content in human abdominal aortic aneurysms. J. Vasc. Surg. 10, 365–373 (1989)
135. Rossaak, J.I., Van Rij, A.M., Jones, G.T., Harris, E.L.: Association of the 4G/5G polymorphism in the promoter region of plasminogen activator inhibitor-1 with abdominal aortic aneurysms. J. Vasc. Surg. 31(5), 1026–1032 (2000)
136. Rouis, M., Adamy, C., Duverger, N., et al.: Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-1 reduces atherosclerotic lesions in apolipoprotein E-deficient mice. Circulation 100(5), 533–540 (1999)
137. Ruddy, J.M., Jones, J.A., Spinale, F.G., Ikonomidis, J.S.: Regional heterogeneity within the aorta: relevance to aneurysm disease. J. Thorac. Cardiovasc. Surg. 136(5), 1123–1130 (2008)
138. Sakalihasan, N., Heyeres, A., Nusgens, B.V., et al.: Modifications of the extracellular matrix of aneurysmal abdominal aortas as a function of their size. Eur. J. Vasc. Surg. 7, 633–637 (1993)
139. Sakalihasan, N., Delvenne, P., et al.: Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms. J. Vasc. Surg. 24(1), 127–133 (1996)
140. Sakalihasan, N., Pincemail, J., Defraigne, J.O., et al.: Decrease of plasma vitamin E (alpha-tocopherol) levels in patients with abdominal aortic aneurysm. Ann. N. Y. Acad. Sci. 800, 278–282 (1996)
141. Sakalihasan, N., Van Damme, H., Gomez, P., et al.: Positron emission tomography (PET) evaluation of abdominal aortic aneurysm (AAA). Eur. J. Vasc. Endovasc. Surg. 23(5), 431–436 (2002)
142. Sakalihasan, N., Limet, R., Defawe, O.D.: Abdominal aortic aneurysm. Lancet 365(9470), 1577–1589 (2005)
143. Schlösser, F.J., Vaartjes, I., van der Heijden, G.J., et al.: Mortality after elective abdominal aortic aneurysm repair. Ann. Surg. 251(1), 158–164 (2010)
144. Scott, R.A., Ashton, H.A., Kay, D.N.: Abdominal aortic aneurysm in 4237 screened patients: prevalence, development and management over 6 years. Br. J. Surg. 78(9), 1122–1125 (1991)
145. Shah, P.K.: Inflammation, metalloproteinases, and increased proteolysis: an emerging pathophysiological paradigm in aortic aneurysm. Circulation 96(7), 2115–2117 (1997)
146. Shantikumar, S., Ajjan, R., Porter, K.E., Scott, D.J.: Diabetes and the abdominal aortic aneurysm. Eur. J. Vasc. Endovasc. Surg. 39, 200–207 (2010)
147. Shi, G.P., Sukhova, G.K., Grubb, A., et al.: Cystatin C deficiency in human atherosclerosis and aortic aneurysm. J. Clin. Invest. 104(9), 1191–1197 (1999)
148. Shibamura, H., Olson, J.M., van Vlijmen-Van Keulen, C., et al.: Genome scan for familial abdominal aortic aneurysm using sex and family history as covariates suggests genetic heterogeneity and identifies linkage to chromosome 19q13. Circulation 109, 2103–2108 (2004)
149. Shiraya, S., Miyake, T., Aoki, M., et al.: Inhibition of development of experimental aortic abdominal aneurysm in rat model by atorvastatin through inhibition of macrophage migration. Atherosclerosis 202(1), 34–40 (2009)
150. Silence, J., Lupu, F., Collen, D., Lijnen, H.R.: Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with Stromelysin-1 (MMP-3) gene inactivation. Arterioscler. Thromb. Vasc. Biol. 21(9), 1440–1445 (2001)
151. Singh, K., Bonaa, K.H., Jacobsen, B.K., Bjork, L., Solberg, S.: Prevalence of and risk factors for abdominal aortic aneurysms in a population-based study: the Tromso Study. Am. J. Epidemiol. 154(3), 236–244 (2001)
152. Slaney, S.G.: A history of aneurysm surgery. In: Greenhalgh, R.M., Mannick, J.A. (eds.) The Cause and Management of Aneurysm, pp. 1–19. WB Saunders Co., London (1990)
153. Tamarina, N.A., McMillan, W.D., Shively, V.P., Pearce, W.H.: Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta. Surgery 122, 264–271 (1997)
154. Thomas, M., Gavrila, D., McCormick, M.L., et al.: Deletion of p47phox attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice. Circulation 114, 404–413 (2006)
155. Thompson, M.M.: Controlling the expansion of abdominal aortic aneurysms. Br. J. Surg. 90(8), 897–898 (2003)
156. Thompson, R.W., Geraghty, P.J., Lee, J.K.,: Abdominal aortic aneurysms: basic mechanisms and clinical implications. Curr. Probl. Surg. 39, 110–230 (2002).
157. Thompson, R.W., Parks, W.C.: Role of matrix metalloproteinases in abdominal aortic aneurysms. Ann. N. Y. Acad. Sci. 800, 157–174 (1996). Review
158. Tilson, M.D.: Aortic aneurysms and atherosclerosis. Circulation 85(1), 378–379 (1992)
159. Tilson, M.D., Seashore, M.R.: Fifty families with abdominal aortic aneurysms in two or more first-order relatives. Am. J. Surg. 147, 551–553 (1984)
160. Towbin, J.A., Casey, B., Belmont, J.: The molecular basis of vascular disorders. Am. J. Hum. Genet. 64(3), 678–684 (1999)
161. Tromp, G., Kuivaniemi, H.: How does one study genetic risk factors in a complex disease such as aneurysm. In: Sakalihasan, N., Kuivaniemi, H., Michel, J.B. (eds.) Aortic Aneurysms, New insights into an old problem, pp. 115–144. Liege University Press, Liege, Belgium (2008)
162. Tromp, G., Kuivaniemi, H.: Developments in genomics to improve understanding, diagnosis and management of aneurysms and peripheral artery disease. Eur. J. Vasc. Endovasc. Surg. 38, 676–682 (2009)
163. Tromp, G., Gatalica, Z., Skunca, M., et al.: Elevated expression of matrix metalloproteinase-13 in abdominal aortic aneurysms. Ann. Vasc. Surg. 18(4), 414–420 (2004)
164. Tromp, G., Kuivaniemi, H., Hinterseher, I., Carey, D.J.: Novel genetic mechanisms for aortic aneurysms. Curr. Atheroscler. Rep. 12, 259–266 (2010)
165. Truijers, M., Kurvers, H.A., Bredie, S.J., et al.: In vivo imaging of abdominal aortic aneurysms; increased FDG uptake suggests inflammation in the aneurysmal wall. J. Endovasc. Ther. 15(4), 462–467 (2008)
166. UK Small Aneurysm Trial Participants: Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. Lancet 352, 1649–1655 (1998)
167. UK Small Aneurysm Trial Participants: Long-term outcomes of immediate repair compared with surveillance of small abdominal aortic aneurysms. N. Engl. J. Med. 346(19), 1445–1452 (2002)
168. Van Kuijk, Jp.P., Flu, W.J., Witteveen, O.P., et al.: The influence of statins on the expansion rate and rupture risk of abdominal aortic aneurysms. J. Cardiovasc. Surg. (Torino) 50(5), 599–609 (2009)
169. Van Vlijmen-Van Keulen, C.J., Rauwerda, J.A., Pals, G.: Genome-wide linkage in three Dutch families maps a locus for abdominal aortic aneurysms to chromosome 19q13.3. Eur. J. Vasc. Endovasc. Surg. 30, 29–35 (2005)
170. Vardulaki, K.A., Walker, N.M., Day, N.E., et al.: Quantifying the risks of hypertension, age, sex and smoking in patients with abdominal aortic aneurysm. Br. J. Surg. 87(2), 195–200 (2000)
171. Verloes, A., Sakalihasan, N., Koulischer, L., et al.: Aneurysms of the abdominal aorta: familial and genetic aspects in three hundred thirteen pedigrees. J. Vasc. Surg. 21, 646–655 (1995)
172. Visel, A., Zhu, Y., May, D., et al.: Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice. Nature 464, 409–412 (2010)
173. Vollmar, J.F., Pauschinger, P., Paes, E., et al.: Aortic aneurysms as a late sequellae of above-knee amputation. Lancet ii, 834–835 (1989)
174. Vorp, D.A., Lee, P.C., Wang, D.H., et al.: Association of intraluminal thrombus in abdominal aortic aneurysm with local hypoxia and wall weakening. J. Vasc. Surg. 34(2), 291–299 (2001)
175. Wagenseil, J.E., Mecham, R.P.: Vascular extracellular matrix and arterial mechanics. Physiol. Rev. 89, 957–989 (2009)
176. Wahlgren, C.M., Larsson, E., Magnusson, P.K., et al.: Genetic and environmental contributions to abdominal aortic aneurysm development in a twin population. J. Vasc. Surg. 51, 3–7 (2010)
177. Walton, L.J., Franklin, I.J., Bayston, T., et al.: Inhibition of prostaglandin E2 synthesis in abdominal aortic aneurysms: implications for smooth muscle cell viability, inflammatory processes, and the expansion of abdominal aortic aneurysms. Circulation 100(1), 48–54 (1999)
178. Weinsheimer, S., Lenk, G.M., van der Voet, M., et al.: Integration of expression profiles and genetic mapping data to identify candidate genes in intracranial aneurysm. Phys. Genomics 32, 45–57 (2007)
179. Weiss, J.S., Sumpio, B.E.: Review of prevalence and outcome of vascular disease in patients with diabetes mellitus. Eur. J. Vasc. Endovasc. Surg. 31(2), 143–150 (2006)
180. Wilmink, T.B., Quick, C.R., Hubbard, C.S., Day, N.E.: The influence of screening on the incidence of ruptured abdominal aortic aneurysms. J. Vasc. Surg. 30(2), 203–208 (1999)
181. Xiong, W., Mactaggart, J., Knispel, R., et al.: Inhibition of reactive oxygen species attenuates aneurysm formation in a murine model. Atherosclerosis 202(1), 128–134 (2009)
182. Xu, C., Zarins, C.K., Glagov, S.: Aneurysmal and occlusive atherosclerosis of the human abdominal aorta. J. Vasc. Surg. 33(1), 91–96 (2001)
183. Xu, X.Y., Borghi, A., Nchimi, A., et al.: High levels of 18F-FDG uptake in aortic aneurysm wall are associated with high wall stress. Eur. J. Vasc. Endovasc. Surg. 39(3), 295–301 (2010)
184. Yajima, N., Masuda, M., Miyazaki, M., et al.: Oxidative stress is involved in the development of experimental abdominal aortic aneurysm: a study of the transcription profile with complementary DNA microarray. J. Vasc. Surg. 36(2), 379–385 (2002)
185. Yamasumi, K., Ojiro, M., Okumura, H., Aikou, T.: An activated state of blood coagulation and fibrinolysis in patients with abdominal aortic aneurysm. Am. J. Surg. 175(4), 297–301 (1998)
186. Yasuda, H., Nakatani, S., Stugaard, M., et al.: Failure to prevent progressive dilation of ascending aorta by aortic valve replacement in patients with bicuspid aortic valve: comparison with tricuspid aortic valve. Circulation 108(Suppl 1), II291–II294 (2003)
187. Yasuno, K., Bilguvar, K., Bijlenga, P., et al.: Genome-wide association study of intracranial aneurysm identifies three new risk loci. Nat. Genet. 42, 420–425 (2010)
188. Zhang, J., Schmidt, J., Ryschich, E., et al.: Inducible nitric oxide synthase is present in human abdominal aortic aneurysm and promotes oxidative vascular injury. J. Vasc. Surg. 38(2), 360–367 (2003)
189. Zhu, L., Vranckx, R., Khau Van Kien, P., et al.: Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. Nat. Genet. 38, 343–349 (2006)